跳至主要内容
临床试验/IRCT20081208001497N10
IRCT20081208001497N10招募中3 期

Evaluation of the effect of licorice as an adjunct treatment for patients with Covid-19 admitted to the intensive care unit: A randomized, placebo-controlled, double-blind clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Covid-19 diagnosis based on PCR test
  • Hospitalized in the intensive care unit and under mechanical ventilation

排除标准

  • 1. Patients with high blood pressure (<90/140)
  • Patients with congestive heart failure
  • Patients with severe liver, kidney and thyroid disease
  • Concomitant use of warfarin, SSRI, MAOI, diuretics, antiarrhythmic drugs
  • Treatment with antiviral drugs one month before entering the study
  • Allergy to licorice
  • Pregnancy and lactation
  • Dissatisfaction of the patient or his legal guardian
  • Infected with Covid-19 for at least 20 days prior to enrollment

研究者

相似试验